NCT01587729View on ClinicalTrials.gov

IMI PROTECT(WP2): Antidepressants & Fractures

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Depression, Postpartum
Interventions
DRUG

Tricyclic AD (TCAs) and selective serotonin re-uptake inhibitors (SSRIs) antidepressants

TCA or SSRI prescription during the study period between January 1, 2001 and December 31, 2009. The TCAs and SSRIs administered to the patients include paroxetine and escitaloprim.

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01587729 - IMI PROTECT(WP2): Antidepressants & Fractures | Biotech Hunter | Biotech Hunter